The obligate intracellular parasite Toxoplasma gondii is able to infect nearly all nucleated cell types of warm-blooded animals. This is achieved through the injection of hundreds of parasite effectors into the host cell cytosol allowing the parasite to establish a vacuolar niche for growth, replication and persistence. Here we show that Toxoplasma
Toxoplasma gondii is among the most successful protozoan parasites, exhibiting an extremely broad host range. While rodents are thought to be a natural host for the parasite, Toxoplasma is also a relevant human pathogen, with infection rates ranging from 10% (U.S.) to 65% (France and Brazil) of the population world wide (1) .
Toxoplasma is acquired through ingestion of oocysts or tissue cysts (bradyzoites) in food or contaminated water. Once they have crossed the intestinal barrier the parasites convert into rapidly dividing tachyzoites that traffic through the host in infected leukocytes (2) . In order to complete the infectious cycle, the parasite must convert to the bradyzoite form, most abundant in the brain and muscle. While immuno-competent hosts are largely asymptomatic, infection of immuno-suppressed individuals results in encephalitis, heart and lung damage. As such, the ability to raise an effective immune response is critical to the survival and success of both the host and the parasite. Cumulatively, these observations suggest that mammalian hosts have been under a stringent selective pressure to develop specific mechanisms to sense and suppress the activity of Toxoplasma.
The parasite's ability to invade and persist within host cells, often for the life of an individual, is achieved through the secretion of a large number of molecules into the host cell cytosol. Many of these secreted/injected proteins function as "effectors", intersecting host signaling pathways like ROP16 which acts as a mimic of host JAK kinases, phosphorylating STAT-3 and STAT-6 (3, 4) . ROP5 and ROP18 cooperate to interfere with immunity-related GTPases blocking their attack of the parasitophorous vacuole membrane (5, 6) . Dense granule proteins have recently been shown to enter the host cytoplasm where they can interact with crucial host functions (7, 8) . This biology is conserved across the three major strains of Toxoplasma that predominate Europe and North America, referred to as Type I, Type II and Type III, though, allelic differences in some of the secreted proteins appears to dictate differences in the virulence between types. The full extent of how Toxoplasma uses secretion to co-opt the host cell is not yet known, especially as regards interaction with the innate immune surveillance systems.
Inflammasomes are sensor systems used to survey the host cell cytosol, a normally sterile compartment, for microbial ligands or abnormal host cell biology as signatures of infection. The ability to recognize and respond to a diverse set of stimuli is achieved through the modular use of multiple sensors belonging to the NLRP and the PYRIN/HIN families. These sensors interact with caspase1 or caspase11 directly or via the linker ASC leading to multimerization of inflammasome complexes. The downstream secretion of IL-1-family cytokines and pyroptotic cell death leads to the recruitment of other inflammatory cells to the region and limits intracellular pathogen replication. NLRP1, the first inflammasome characterized, is activated by Bacillus anthracis the causative agent of anthrax (9) . N-terminal cleavage of the sensor by the proteolytic component of anthrax lethal toxin, the so-called "lethal factor" (LF), leads to robust ASC-and caspase1-dependent IL-1 release and cell death (10, 11) . This sensing mechanism is responsible for an 'early-response phenotype" characterized by ataxia, loose stool and dilated blood vessels in response to live Bacillus anthracis spores that restricts bacterial dissemination but can lead to host death in response to the purified toxin (12, 13) . Type II strains of Toxoplasma elicit IL-1 secretion from human monocytes (14) . This is consistent with GWAS results that identified SNPs in nlrp1 and the NLRP3 inflammasome activator p2x7r associated with susceptibility to congenital Toxoplasmosis, and the finding that NLRP1 knockdown in a human monocyte line enhanced Toxoplasma growth (15, 16). However, a definitive study to determine if there is a sensor in the host cell cytosol that detects Toxoplasma directly or a description of the role inflammasome plays in Toxoplasma infection have not been completed. The work described here addresses both these questions.
Taconic. All animal protocols were approved by Stanford University's Administrative Panel on Laboratory Animal Care (Animal Welfare Assurance # A3213-01, protocol # 9478). All animals were housed and treated in accordance with AAALAC and IACUC guidelines at the Stanford School of Medicine Veterinary Service Center.
Parasites, cells and cell lines
The following parasite strains were used Type I, RH88; Type II, Pru or Me49;
Type III, CEP. The Neospora caninum used was the NC-1 strain. RH88 and Me49 strains stably expressing green fluorescent protein and luciferase were previously described (17) .
Parasites were passaged intracellularly in human foreskin fibroblasts (ATCC) and passaged by 25G syringe lysis in complete DMEM (cDMEM, Gibco) plus 10% FBS (HiClone), 100ug Penicillin-Streptomycin (Gibco) and 1mM Sodium Pyruvate (Gibco).
Mouse BMDMs were generated from femurs of 6-8 week old mice, and differentiated 6 days in cDMEM plus 20% supernatant from L929 cells expressing mouse MCSF. Rat BMDM media was supplemented with 30ng/mL recombinant rat MCSF (ProSpec).
Immortalized BMDMs stably expressing NLRP1 constructs were previously described (10) . NLRP1 constructs expressed in the MSCV2.2 retroviral vector were transiently transfected in 293T/17 cells (ATCC) using lipofectamine LTX (Invitrogen) according to the manufacturer's directions.
Supernatant ELISAs and LDH assays
BMDMs were plated at x per well in 96-well plates or x per well in 24-well plates in cDMEM. 12 hours or 2 hours prior to infection media was exchanged for cDMEM containing 100ng/mL ultra-pure LPS or 500ng/mL Pam3CSK4. Intracellular parasites or mock-infected HFFs controls (UI-SUP) were syringe-lysed through a 25G 
Immunoblots
293T cells were seeded at 1x cells per well in 6-well plates and infected as described above. Cells were scraped in PBS, pelleted and lysed in RIPA buffer (50mM 
Microscopy
Cells were imaged in tissue culture dishes or plated on coverslips coated with poly-D-lysine (Sigma). Cells were fixed in 2.5% formaldehyde in PBS or stained with 5µL/mL propidium iodide (BioLegend) in PBS for 10 minutes prior to fixation.
Coverslips were mounted in Vectashield (Vector Laboratories) imaged on an Olympus BX60 upright fluorescence microscope with a 20x or 40x objective.
In vivo infections
To generate cysts 6-8 week-old female CBA/J mice were infected with 1000 system. To image organs, mice were injected 10 minutes prior to euthanasia and organs were imaged as described. Images were analyzed with LivingImage software and ImageJ.
For quantification, brain cysts were harvested and stained as described for CBA/Js except that brain mash was fixed for 20 minutes in 2.5% formaldehyde in PBS prior to dolichosrhodamine staining.
12-week-old male Swiss Webster mice housed in germ-free or restricted-flora micro isolators were used in gnotobiotic experiments. Brain cysts (or mock infected brains) were prepared under sterile conditions then vials containing infectious doses were decontaminated for 2 hrs prior to infection on ¼ piece of mouse diet. Parasite load and dissemination were monitored by BLI as described above. Sera were collected at sacrifice and cytokines were measured by Luminex bead assay (Illumina) at the Stanford Human
Immune Monitoring Center. resistance phenotype (18) . Peritoneal exudate cells isolated from these rats and infected in vitro were able to restrict parasite replication in a manner that correlated with decreased host cell number over the course of the experiment. Interestingly, the toxo1 interval overlaps with the rat susceptibility locus to anthrax lethal factor (LF), mapped in a cross between BN and SHR rats, that contains and is controlled by NLRP1 (19) . Based on these observations, we hypothesized that the inflammasome may be involved in
Results

Macrophages from rat strains resistant to
Toxoplasma-restrictive response of Lewis rats and rat macrophages.
To examine inflammasome activation, bone-marrow-derived macrophages Figure 1D ). Whereas by this time B6 mice appeared to have cleared most of the infection from the periphery, parasites were still detected in the gut and testes of caspase1/11 KO by BLI ( Figure 1E , white asterisks; Figure 1F ). Cumulatively, these data strongly suggest that caspase1/11-mediated inflammasome responses control parasite burden and /or dissemination in the mouse. (Figure 2A ). Parasite load was determined 9 dpi by BLI. Importantly, Toxoplasma was detected in the small intestine, mesenteric lymph node and spleen of GF mice, suggesting that the parasites are able to colonize and disseminate to these organs in the absence of commensal microbiota ( Figure 2B ). In addition to generating comparable levels of IFN-and IL-12, hallmarks of a response to Toxoplasma infection, GF mice were able to generate a robust IL-1 response to parasite infection ( Figure 2C ). Infection status of the mice was verified by serology and the "germ-free" status of the GF mice (excepting Toxoplasma) was confirmed by PCR at sacrifice (data not shown). As Figure 1) . Macrophage morphology changed following Toxoplasma infection and, consistent with previous reports, there was an increase in host membrane permeability leading to a low but noticeable staining with dyes like propidium iodide when compared to uninfected controls ( Figure 3B ) (27) . However, this staining was distinct from the nuclear PI staining observed following ATP treatment, a well-studied To determine if known inflammasome components were required for IL-1 secretion in response to Toxoplasma, BMDMs from mice deficient in various inflammasome components were infected. The IL-1 response to Toxoplasma was reduced to near background levels when we infected BMDMs from caspase1/11 double KO mice as well as ASC KO mice, consistent with interpretation that the IL-1 secretion observed is inflammasome-mediated ( Figure 3C ). Although we noted that Toxoplasma led to a modest release of the cytosolic enzyme lactate dehydrogenase (LDH) into the culture supernatant, we found that the majority of this release was caspase1/11-and ASCindependent ( Figure 3D ). This may be the result of damage to a minority of cells in the infected culture, for example through spontaneous parasite egress, or the result the lowgrade membrane permeability noted in PI-staining experiments ( Figure 3B ). Either way, the LDH release observed appears to be largely inflammasome-independent suggesting that, in contrast to our observations in the rat where Toxoplasma infection induces pyroptosis, there is not a robust pyroptotic response to Toxoplasma in B6 BMDMs. Figure 2A and B) .
The 129 allele of NLRP1b is sufficient to enhance the inflammasome response to Toxoplasma independent of the lethal factor cleavage sites. The result that a major component of the inflammasome response to Toxoplasma in mouse was NLRP3-independent raised the possibility that another sensor directly detects the parasite.
Combined with the observation that the restrictive phenotype in Lewis rats mapped to a genomic interval containing NLRP1 and our finding that Lewis BMDMs secrete IL-1 and pyroptose in response to the parasite, we hypothesized that NLRP1 may be involved in the response to Toxoplasma. In contrast to the rats, which have a single nlrp1 gene, mice have an expanded NLRP1 locus encompassing three paralogues of the sensor: Figure 4A and data not shown). As previously described, B6 BMDMs do not respond to anthrax lethal factor whereas 129 BMDMs are sensitive; however, both respond robustly to extracellular ATP in the context of LPS priming ( Figure 4A ).
To directly test the possibility that the 129 allele of nlrp1b (NLRP1b 129 ) was sufficient to drive a more robust response to the parasite, we infected B6 immortalized Figure 4F ). While we cannot definitively rule an undetectable level of cleavage, these data are consistent with the interpretation that NLRP1 activation in response to the Toxoplasma occurs via a novel, non-proteolytic mechanism.
Discussion
The result that the mouse NLRP1b 129 can drive an inflammasome response to Toxoplasma in the absence of the lethal factor proteolysis sites, and likely receptor processing in general, is consistent with our observation that Lewis rats, which express an allele of NLRP1 that cannot be processed by LF, are highly responsive to Toxoplasma.
Interestingly, while NLRP1bmice still generate a robust, albeit lower, response to the parasite. Although the B6 allele of nlrp1b is not responsive to LF, it is possible that NLRP1b B6 is sensitive to Toxoplasma infection and accounts for the inflammasome response observed on this background.
Given that NLRP1a is a nearer homologue of rat and human NLRP1, it is also possible that this paralog or possibly even another NLRP plays a role in the B6 response to the parasite; we think this is unlikely, however, as we do not see an additive effect in the response from BMDMs derived from an F1 cross between B6 and 129 mice (data not shown).
The precise mechanism of NLRP1 activation in response to the parasite and whether this is a response exclusive to Toxoplasma or conserved across other protozoan parasites remain to be determined. To date, only two mechanisms of inflammasome activation have been described: NLRP1 proteolysis by lethal factor and Naip binding directly to flagelin or the type III secretion apparatus to trigger a caspase1-dependent inflammasome through NLRC4 (32, 33) . There is evidence that the lethal toxin nonresponsive BALB/c allele can still be processed by lethal factor, albeit at a different site from that observed for the sensitive NOD/129 allele, suggesting that not all proteolytic events are sufficient for sensor activation (34) . While it is clear that Toxoplasma 
